The expression of distinct variant isoforms of the cell surface glycoprotei
n CD44 (CD44v) has been found to be associated with metastatic potential of
rodent adenocarcinoma cells and with an altered prognosis in several types
of human cancer. In hormone-dependent gynecological cancers, different CD4
4v expression patterns have been observed. The influence of ovarian steroid
hormones and their antagonists on CD44v expression is still unclear, since
there are only retrospective correlation studies so far. Therefore, we exa
mined the CD44 mRNA expression in a standardized Stimulation experiment in
a number of breast and endometrial carcinoma cell lines varying in estrogen
receptor (ER) status. Higher CD44 overall expression was observed in ER po
sitive endometrial and breast carcinoma cell lines when compared to corresp
onding ER negative cell lines. The number and composition of alternatively
spliced isoforms showed no clear correlation to the ER expression status. T
hree CD44v isoforms were detected in all cell lines expressing CD44v, two o
f which have not been reported previously in normal endometrial cells. Thes
e isoforms may have specific functions in this type of carcinoma. In the se
cond part of the study, the influence of (anti-) hormones on CD44 expressio
n in endometrial carcinoma cell lines was examined. CD44 overall expression
showed an increase when the cells were grown in medium containing fetal ca
lf serum (FCS) as compared to cells maintained in medium-free of FCS. CD44
expression was transiently increased by estradiol (1 h). The CD44 splice pa
ttern of endometrial cancer cell lines RL95-2 and Hec-1-A, after treatment
with (anti-) hormones showed constant and high expression rates for distinc
t CD44v-isoforms such as CD44E (CD44v8-v10), Only certain weakly expressed
isoforms changed their expression level during the experimental period, but
no direct Correlation to hormone treatment was observed. In conclusion, es
tradiol or FCS increase CD44 overall expression, but there seems to be no d
irect influence of ovarian steroid hormones on the CD44v splice machinery i
n endometrial carcinoma cell lines.